Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ascorbic Acid Administration on Restenosis of Dysfunctional Hemodialysis Vascular

NCT03524846 is registered in ClinicalTrials.gov with National Taiwan University Hospital Hsin-Chu Branch as lead sponsor.

NCT NCT03524846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03524846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ascorbic Acid Administration on Restenosis of Dysfunctional Hemodialysis Vascular
Lead sponsor
National Taiwan University Hospital Hsin-Chu Branch
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
October 31, 2011
Enrollment
93 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis access failure